Pay in 4 interest-free payments of $6.35 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Dietary supplements can provide additional support but should be used with caution
Other risks include bone fractures and osteoporosis later in life
Last updated: July 29, 2026 IMCIVREE (setmelanotide) market dynamics and financial trajectory: sales drivers, pricing pressure, payer coverage, and exclusivity risk Executive summary: IMCIVREE (setmelanotide) has a narrow but growing addressable population across rare genetic obesity (POMC, PCSK1, LEPR deficiencies)
The original packaging protects it from harmful light
US$ 25.42
US$ 27.74
US$ 28.50
US$ 26.51
US$ 24.62
